Pharmaceutical / Drug Definition :
Inhibits reabsorption of sodium and chloride in distal renal tubules and ascending limb of loop of Henle; increases renal excretion of water, sodium, chloride, magnesium, hydrogen, and calcium. Also reduces increased fluid volume caused by renal vasodilation.
In the United States, Bumetanide is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Bumetanide.
Registrar Corp assists Bumetanide companies with:
FDA Label Requirements and Exceptions
FDA Import Information
Bumetanide (Bumetanide Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Bumetanide (Bumetanide Suppliers)
- Processors Bumetanide
- Repackers Bumetanide
- Relabelers Bumetanide
- Exporters Bumetanide
- Importers Bumetanide
For more information about Bumetanide, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.